HUL takes Beco to Delhi HC over campaign targeting Vim and Surf Excel
HUL has sought an injunction against Beco’s campaign alleging that ingredients in Vim and Surf Excel can cause skin irritation. The sustainable home-care brand says its comparative claims are independently tested and scientifically substantiated.
What happened
Hindustan Unilever · HUL has sought a Delhi High Court injunction against sustainable home-care brand Beco’s campaign alleging Vim and Surf Excel ingredients
Key facts
- $13.4 Mn
- 2018
- August 14
Why this matters
For acquirers and partners, the dispute underscores the need to diligence a target’s comparative-advertising evidence, litigation exposure and ability to defend differentiated sustainability claims.
What to watch
- Delhi High Court interim-order language, especially whether it distinguishes factual ingredient comparisons from implied skin-harm claims.
- Publication of Beco's test protocols, sample sizes, accredited-lab credentials, product versions tested and scientific basis for causation.
- Whether Beco alters, withdraws or continues the disputed campaign during proceedings.
- HUL's follow-on safety campaign, changes in Vim or Surf Excel claims, and any consumer-facing ingredient transparency initiative.
- ASCI complaints or parallel challenges involving comparative claims in detergents, dishwash and adjacent personal-care categories.
- Social listening for increased searches and discussion around detergent ingredients, skin sensitivity and sustainable alternatives.
- HUL is likely to seek rapid interim relief, arguing that the campaign creates an unqualified safety inference and causes reputational harm before trial.
- Beco will foreground laboratory reports, testing methodology, expert endorsements and sustainability credentials across PR and owned channels.
- HUL may counter with reassurance advertising around product safety, dermatological testing, usage instructions and long-standing consumer trust.
- Other home-care marketers may reduce direct competitor references and add stronger evidence/disclaimer processes for ingredient and health-adjacent claims.
- Retailers and marketplaces may face requests to pause, amend or monitor campaign-linked creative if an interim order is issued.